Therapeutic Management Options for. Acute Ischemic Stroke Anna Rosenbaum, MD
|
|
- Noah Doyle
- 8 years ago
- Views:
Transcription
1 Therapeutic Management Options for Acute Ischemic Stroke Anna Rosenbaum, MD
2 Epidemiology Epidemiology 4 th leading cause of death in the United States 1 Leading cause of disability Increase in projected stroke related medical costs from billion to $ billion 2 1 Heart disease and stroke statistics 2013 update: a report from the American Heart Association. Circulation. 2013;127:e6 e245 2 Ovbiagele B, et al. Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke. 2013;44:
3 Acute Reperfusion Therapy IV Thrombolysis IV rtpa Mechanical embolectomy/endovascular therapy
4 IV TPA Tissue plasminogen activator Mechanism: serine protease that inhibits plasmin degradation of fibrin FDA approved in 1995 Number needed to treat to prevent 1 death/disability: 8 within 3 hour window 3 14 within 4.5 hour window 4 Overall absolute benefit of treatment is a 13% lower rate of significant disability 3 Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-pa Stroke Study Group. NEJM, 1995;333(24): Hacken, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-pa stroke trials. Lancet 2004;363(9411):
5 IV TPA FDA approved for use within 3 hours Not FDA approved for hour window, but recommended based on available evidence (ECASS III) 5 Every 30 minute delay in administration leads to 10% reduction in good outcome Treatment times beyond 270 minutes have no benefit 5 Hacke, et al. Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke. N Engl J Med 2008; 359:
6 Door to Needle Time Timeline - ED physician: 10 minutes of arrival - Stroke consultant is notified within 15 minutes of arrival - CT scan is completed within 25 minutes of arrival - CT is interpreted within 45 minutes of arrival Marler JR, et al. Proceedings of a national symposium on rapid identification and treatment of acute stroke. Bethesda, MD: The National Institute of Neurologic Disorders and Stroke (NINDS), National Institutes of Health, 1997;97:4239 Inclusion/Exclusion - Last known normal ( wake up strokes excluded) - Any significant medical history - NIHSS - Glucose level (finger stick) - Other significant laboratory results - Current blood pressure - Results of acute brain imaging (CT scan +/- CTA)
7 Exclusion Criteria Evidence of intracranial hemorrhage on pretreatment CT scan Minor or rapidly improving symptoms Symptoms of subarachnoid hemorrhage, even with normal head CT Active internal bleeding: Gastrointestinal or urinary bleeding within last 21 days Platelet count less than 100,000/mm3 Heparin during the preceding 48 hours associated with elevated aptt Currently taking oral anticoagulants (e.g. Warfarin sodium) or recent use with an elevated prothrombin time (PT) greater than 15 seconds or INR greater than 1.7 Major surgery or other serious trauma during preceding 14 days Stroke, serious head trauma or intracranial surgery during preceding 3 months Recent arterial puncture at a non-compressible site Recent lumbar puncture during preceding 7 days Systolic BP > 185 mm of Hg or diastolic BP > 110 mm of Hg at the time of t-pa infusion and/or patient requires aggressive treatment to reduce blood pressure Any history of intracranial hemorrhage, neoplasm, arteriovenous malformation, Presenter or aneurysm name Recent Acute Myocardial Infarction Observed seizure at stroke onset
8 Exclusion criteria (con t) Relative Contraindications: Early signs of a large cerebral infarction: edema, hypodensity, mass effect, and obliteration of sulci in > 1/3 of middle cerebral artery territory on CT scan. NIHSS greater than 22 Glucose less than 50 mg/dl or greater than 400 mg/dl. Pregnant female Difficult to control hypertension Age greater than 75
9 Exclusion criteria: hour window History of stroke AND diabetes mellitus NIHSS score >25 > 80 years old Any warfarin use (regardless of INR value)
10 Candidate selection: Exclusion criteria Rapidly improving deficits/low stroke scales - Not necessarily a contraindication to tpa (unless minor deficit) - complete hemianiopsia - severe aphasia - visual/sensory extinction - any weakness limiting sustained effort against gravity Re-examining Acute Eligibility for Thrombolysis (TREAT) Task Force, Stroke. ahajournals.org/content/44/9/2500.abstract.
11 Early ischemic changes on CT Early ischemic changes on CT scan are not contraindications: loss of grey-white matter differentiation Hypoattenuation loss of insular ribbon hyperdense artery signs (MCA) sulcal effacement
12
13 Completed stroke
14 ICH Symptomatic intracranial hemorrhage NINDS 6.4% (3 hr. window) ECASS III 7.9% (4.5 hour window) Stroke mimics (seizure, migraine) risk of ICH is less than 1% Jauch EC, Saver JL, Adams HP, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke
15 Stroke Mimics - not a contraindication Extremely low rate of symptomatic ICH (<1%) Complicated migraine (migraine with focal deficits) Seizure (Todd s paralysis) Tsivgoulis G, Alexandrov AV, Chang J, et al. Safety and outcomes of intravenous thrombolysis in stroke mimics: a 6-year, single-care center study and pooled analysis of reported series. Stroke 2011;42(6):
16 For every 100 patients treated Hours from symptom onset with tpa Excellent outcome Number helped Number harmed Liklihood of help vs. harm Pooled data from 7 trials (NINDS 1&2, ECASS I, II, II, ATLANTIS A&B)
17 Figure 1-2 Figure 1-2 Changes in final outcome as a result of intravenous recombinant tissuetype plasminogen activator (IV rtpa) treatment within 3 hours of onset. Reprinted from Saver JL, Medscape.7emedicine.medscape.com/arti cle/ overview. P. Kaatri. CONTINUUM: Lifelong Learning in Neurology. Copyright 2014 American Academy of Neurology. Published by Lippincott Williams & Wilkins. 17
18 Mechanical Thrombectomy Who should be considered? Patients ineligible for IV rtpa 3 hr. time window: on coumadin with INR > hr time window: any coumadin Any of the newer oral anticoagulants (rivoroxaban/xarelto, dagibatran/pradaxa, apixiban/eliquis) significant stroke deficits (NIHSS > 8) if treatment can be initiated within 6 hours (based on PROACT II, MELT) 1 comparable safety and efficacy between IV rtpa within 3 hours versus endovascular therapy within Furlan A, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999;282(21):2003Y2011; Ogawa A, et al. Randomized trial of intraarterial infusion of urokinase within 6 hours of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007;38(10) 2 Ciccone A, Valvassori L, Nichelatti M, et al. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013;368(10): (SYNTHESIS)
19 FDA Approved devices Revascularization rates > 80% Stentrievers: Solitaire Trevo Penumbra Aspiration
20 Figure 1-4 Devices cleared by the US Food and Drug Administration for acute stroke clot removal: A, Merci Retriever; B, Solitaire stent retriever; C, Penumbra aspiration system; and D, TREVO2 stent retriever.panel A courtesy of Concentric Medical, Inc; Panel B courtesy of Covidien; Panel C courtesy of Penumbra, Inc; Panel D courtesy of Stryker. Khatri, Pooja CONTINUUM: Lifelong Learning in Neurology. 20(2, Cerebrovascular Disease): , April doi: /01.CON Copyright 2014 American Academy of Neurology. Published by Lippincott Williams & Wilkins. 20
21 IMS III IV rtpa + endovascular therapy vs. IV rtpa alone Results: endovascular therapy + TPA not superior to TPA alone within 6 hours Comparable safety Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-pa versus t-pa alone for stroke. N Engl J Med 2013;368(10)
22 IMS III Subgroups may benefit: NIHSS >20 Large proximal occlusions Carotid terminus Clots > 8 mm Better recanalization than with tpa alone Studies ongoing
23 Beyond 6 hours? Trials ongoing in regard to imaging criteria: MR RESCUE penumbral imaging 1 1 Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med 2013;368(10):
24 Endovascular Therapy Possible candidates for consideration for endovascular therapy beyond 6 hours: Moderate-to-severe deficit (e.g. NIHSS 8) last seen normal or unknown time of symptom onset 24 hour anterior circulation ischemic syndrome 36 hours posterior circulation ischemic syndrome Must have: CT head with < well demarcated hypodensity < 1/3 of the territory MRI (ideally within 1-2 hours of recognition) with DWI abnormality < 1/3 of territory (anterior circulation) or lack of large brainstem DWI abnormality (posterior circulation)
Level III Stroke Center Data Collection Requirements
Who? Level III Stroke Center Data Collection Requirements All LERN Level III Stroke Centers. LERN Level I and II Stroke Centers have reporting requirements to The Joint Commission or other Board approved
More informationAcute Myocardial Infarction (the formulary thrombolytic for AMI at AAMC is TNK, please see the TNK monograph in this manual for information)
ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY Guidelines for Use of Intravenous Alteplase (Tissue Plasminogen Activator (t-pa)), Activase in the Treatment
More informationTPA, STROKE, & TELEMEDICINE. Improving utilization and improving outcomes in a constantly evolving field
TPA, STROKE, & TELEMEDICINE Improving utilization and improving outcomes in a constantly evolving field OVERVIEW tpa inclusion and exclusion evolution Challenges to tpa administration Target:Stroke Telemedicine
More informationUPDATED INCLUSION AND EXCLUSION CRITERIA FOR IV TPA ADMINISTRATION ACUTE STROKE TREATMENT: AN UPDATE GOALS OF TALK
ACUTE STROKE TREATMENT: AN UPDATE James M. Gebel MD MS FAHA Medical Director Akron General Medical Center Cerebrovascular Center GOALS OF TALK Review changes to IV tpa administration as per new 2013 AHA
More informationWhat s New in Stroke?
5 th McMaster University Review Course in INTERNAL MEDICINE What s New in Stroke? Robert Hart, M.D. HHS / McMaster Stroke Program Department of Medicine (Neurology) McMaster University Hamilton, Ontario
More informationThrombolysis for Ischemic Stroke: Past, Present, and Future. LGH Stroke Symposium Oct 26, 2013
Thrombolysis for Ischemic Stroke: Past, Present, and Future LGH Stroke Symposium Oct 26, 2013 1 2 Thrombolytic Therapy Outcomes at 3 Months from tpa Treatment of Stroke 4 Historical Landmarks 5 Other Thrombolytics
More informationDeveloping a Dynamic Team Approach to Stroke Care. Emergency Medical Services 2015
Developing a Dynamic Team Approach to Stroke Care Emergency Medical Services 2015 Why Stroke, Why now? A recent study showed that 80 percent of people in the United States live within an hour s drive of
More informationEMS Management of Stroke. Deaver Shattuck, M.D. Brian Wiseman, M.D. Keith Woodward, M.D.
EMS Management of Stroke Deaver Shattuck, M.D. Brian Wiseman, M.D. Keith Woodward, M.D. Financial Disclosure: No relevant financial relationship exists Working Together to End Stroke Formed in 2013 Identified
More informationTIME LOST IS BRAIN LOST. TARGET: STROKE CAMPAIGN MANUAL
TIME LOST IS BRAIN LOST. TARGET: STROKE CAMPAIGN MANUAL 2010, American Heart Association TARGET: STROKE CAMPAIGN MANUAL 01 INTRODUCTION Welcome to the Target: Stroke. The purpose of this manual is to provide
More informationSTROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE
STROKE PREVENTION AND TREATMENT MARK FISHER, MD PROFESSOR OF NEUROLOGY UC IRVINE CASE REPORT: ACUTE STROKE MANAGEMENT 90 YEAR OLD WOMAN, PREVIOUSLY ACTIVE AND INDEPENDENT, CHRONIC ATRIAL FIBRILLATION,
More informationNOVEL ANTICOAGULANTS
NOVEL ANTICOAGULANTS MAKING EDUCATED GUESSES IN PATIENTS WITH ACUTE ISCHEMIC STROKE IGOR RYBINNIK, M.D. Assistant Professor of Neurology Rutgers Robert Wood Johnson Medical School DISCLOSURES FINANCIAL
More informationAHA/ASA Scientific Statement
AHA/ASA Scientific Statement Metrics for Measuring Quality of Care in Comprehensive Stroke Centers: Detailed Follow-Up to Brain Attack Coalition Comprehensive Stroke Center Recommendations A Statement
More informationAHA/ASA Guideline. Guidelines for the Early Management of Patients with Acute Ischemic Stroke. A Guideline for Healthcare Professionals from the
AHA/ASA Guideline Guidelines for the Early Management of Patients with Acute Ischemic Stroke A Guideline for Healthcare Professionals from the Copyright 2013 American Heart Heart Association Association/American
More informationNew Treatments for Stroke Prevention in Atrial Fibrillation. John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013
New Treatments for Stroke Prevention in Atrial Fibrillation John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013 Classification Paroxysmal atrial fibrillation (AF) Last < 7
More informationMaking the Case for CPG s Jean Luciano, MSN, RN, CNRN, SCRN, CRNP, FAHA Claranne Mathiesen, MSN, RN, CNRN, SCRN, FAHA
Making the Case for CPG s Jean Luciano, MSN, RN, CNRN, SCRN, CRNP, FAHA Claranne Mathiesen, MSN, RN, CNRN, SCRN, FAHA Disclosures Jeanie Luciano Genentech speakers bureau Claranne Mathiesen - none 1 Objective
More informationby Kevin G. Burke, Gregory F. Coplan, David J. Rashid
Time is Brain by Kevin G. Burke, Gregory F. Coplan, David J. Rashid During a stroke, 32,000 brain cells die every minute. 1 Yet every day, patients suffer strokes in the United States without receiving
More informationCurrent thrombolytic therapy in acute ischemic stroke is
ORIGINAL RESEARCH A. Bose H. Henkes K. Alfke W. Reith T.E. Mayer A. Berlis V. Branca S. Po Sit, for the Penumbra Phase 1 Stroke Trial Investigators The Penumbra System: A Mechanical Device for the Treatment
More information4/24/2015. Urgent, STAT, Super STAT, ASAP! Achieving timely lab testing for the Emergency Department. Learning Objectives.
Urgent, STAT, Super STAT, ASAP! Achieving timely lab testing for the Emergency Department Nichole Korpi-Steiner, PhD, DABCC, FACB University of North Carolina Chapel Hill, NC Learning Objectives Describe
More informationHow to manage a patient who needs thrombolysis in acute stroke, ablation or angioplasty/stenting? Janet M McComb Freeman Hospital Newcastle upon Tyne
How to manage a patient who needs thrombolysis in acute stroke, ablation or angioplasty/stenting? Janet M McComb Freeman Hospital Newcastle upon Tyne What do the guidelines say? What happens with warfarin
More informationCerebral Hemorrhage Following Thrombolysis in Stroke
Von Kummer Cerebral Hemorrhage Following Thrombolysis in Stroke Rüdiger von Kummer SUMMARY Hemorrhagic transformation (HT) of ischemic brain tissue occurs in treated and non-treated stroke patients with
More informationTHE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT
THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT Stroke Prevention in Atrial Fibrillation Gregory Albers, M.D. Director Stanford Stroke Center Professor of Neurology and Neurological
More informationStroke Systems of Care
Stroke Systems of Care Ashutosh P. Jadhav, MD PhD Assistant Professor, Neurology and Neurological Surgery Center for Neuro-endovascular Therapy UPMC Stroke Institute Pittsburgh, PA Stroke chain of survival
More informationMedical Management of Ischemic Stroke: An Update. Siddharth Sehgal, MD Medical Director, TMH Neuroscience Center
Medical Management of Ischemic Stroke: An Update Siddharth Sehgal, MD Medical Director, TMH Neuroscience Center Objectives Diagnostic evaluation and management of acute ischemic stroke. Inpatient management
More informationStroke Reperfusion Therapy: IV t-pa Treatment Phase
Stroke Reperfusion Therapy: IV t-pa Treatment Phase IV tpa Administration for Adult Patients Arriving Within 3 Hours. Page Contents Consent Form Indications for IV tpa Contraindications Warnings t-pa Dosing
More informationSCRN Medication Review. Susan M. Gaunt MS APRN ACNS-BC CCRN CNRN Gwinnett Medical Center
SCRN Medication Review Susan M. Gaunt MS APRN ACNS-BC CCRN CNRN Gwinnett Medical Center Objectives To explain the indications, contraindications, interaction, timing, dosing, side effects of: Thrombolytics
More informationSTROKE OCCURRENCE SYMPTOMS OF STROKE
STROKE OCCURRENCE SYMPTOMS OF STROKE The symptoms of stroke depend on what part of the brain is affected and how large an area is involved. A stroke is a sudden event accompanied by one or more of the
More informationAR SAVES. INTRODUCTION AND UPDATES FOR ER PHYSICIANS. Nicolas Bianchi, MD. August 23 rd, 2012.
1 AR SAVES INTRODUCTION AND UPDATES FOR ER PHYSICIANS. Nicolas Bianchi, MD. August 23 rd, 2012. 2 Objectives To provide an introduction and overall description of AR SAVES as a Telestroke Network in the
More informationThe author has no disclosures
Mary Bradbury, PharmD, BCPS Clinical Pharmacy Specialist, Cardiac Surgery September 18, 2012 Mary.bradbury@inova.org This presentation will discuss unlabeled and investigational use of products The author
More informationGP workshop. Maria Fitzpatrick Nurse Consultant Kings College Stroke Centre
GP workshop Maria Fitzpatrick Nurse Consultant Kings College Stroke Centre Stroke: the Facts Stroke: the Facts Every 5 minutes someone in the UK has a stroke 1 in 4 men and 1 in 5 women will have a stroke
More informationEmerging therapies for Intracerebral Hemorrhage
Emerging therapies for Intracerebral Hemorrhage Chitra Venkat, MBBS, MD, MSc. Associate Professor of Neurology and Neurological Sciences Stroke and Neurocritical Care. Stanford University Learning objectives
More informationUMHS In-Patient Acute Ischemic Stroke Treatment Guidelines*
Page 1 UMHS In-Patient Acute Ischemic Stroke Treatment Guidelines* Table of Contents 1) Physician Acute Stroke Checklist 2-3 2) Nursing Orders for Initial Evaluation of Patients with Acute Stroke 3) tpa
More informationSTROKE TRAINING FOR EMS PROFESSIONALS
1 STROKE TRAINING FOR EMS PROFESSIONALS COURSE OBJECTIVES About Stroke Stroke Policy Recommendations Stroke Protocols and Stroke Hospital Care Stroke Assessment Tools Pre-Notification Stroke Treatment
More informationThe Clinical Evaluation of the Comatose Patient in the Emergency Department
The Clinical Evaluation of the Comatose Patient in the Emergency Department patients with altered mental status (AMS) and coma. treat patients who present to the Emergency Department with altered mental
More informationDVT/PE Management with Rivaroxaban (Xarelto)
DVT/PE Management with Rivaroxaban (Xarelto) Rivaroxaban is FDA approved for the acute treatment of DVT and PE and reduction in risk of recurrence of DVT and PE. FDA approved indications: Non valvular
More informationHow To Determine The Percentage Of The Us Population With Access To Ischemic Stroke Care
AJNR Am J Neuroradiol 25:1802 1806, November/December 2004 Access to Intra-Arterial Therapies for Acute Ischemic Stroke: An Analysis of the US Population Shuichi Suzuki, Jeffrey L. Saver, Phillip Scott,
More information4/9/2015. Risk Stratify Our Patients. Stroke Risk in AF: CHADS2 Scoring system JAMA 2001; 285: 2864-71
Anticoagulation in the 21 st Century Adam Karpman, D.O. Saint Francis Medical Center/Oklahoma State University Medical Center Disclosures: None Atrial Fibrillation Most common arrhythmia in clinical practice.
More informationPlanning: Patient Goals and Expected Outcomes The patient will: Remain free of unusual bleeding Maintain effective tissue perfusion Implementation
Obtain complete heath history including allergies, drug history and possible drug Assess baseline coagulation studies and CBC Assess for history of bleeding disorders, GI bleeding, cerebral bleed, recent
More informationStroke An Overview. Dr Declan O Kane MD MRCP(UK) DipCompSci(Cantab) Consultant Physician VOL
Stroke An Overview Dr Declan O Kane MD MRCP(UK) DipCompSci(Cantab) Consultant Physician VOL Stroke - Topics 1. Terminology 2. Prevention primary and secondary 3. Acute treatment 4. Stroke Units and Teams
More informationProtocol: Initial Evaluation and Management of Patients with Ischemic or Hemorrhagic Stroke
PAGE NO. 1 of 6 Original Date of Issue: 7/12/05 Patient Population Neonate Pediatric Reviewed: 2.7.07 1.20.08 3.09 1.10 Adolescent Revised: NA Yes No Yes Adult Geriatric Protocol: Initial Evaluation and
More informationAccreditation and Certification Guidelines
Accreditation and Certification Guidelines MARTIN GIZZI, MD, PHD, FAHA CHAIR, NJ NEUROSCIENCE INSTITUTE AT JFK CHAIR, NORTH EAST CEREBROVASCULAR CONSORTIUM (NECC) CHAIR, STROKE ADVISORY PANEL, NJDOH MEMBER,
More informationAnalyzing Clinical Trial Findings of the Efficacy and Safety Profiles of Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation
Analyzing Clinical Trial Findings of the Efficacy and Safety Profiles of Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation Drew Baldwin, MD Virginia Mason Seattle, Washington NCVH May 29,
More informationCost Effectiveness of Helicopter Transport of Stroke Patients for Thrombolysis
966 Silbergleit et al. d HELICOPTER TRANSPORT IN STROKE Cost Effectiveness of Helicopter Transport of Stroke Patients for Thrombolysis Abstract Objectives: Treatment with intravenous (IV) or intra-arterial
More informationA Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs
A Patient s Guide to Primary and Secondary Prevention of PATIENT EDUCATION GUIDE What Is Cardiovascular Disease? Cardiovascular disease (CVD) is a broad term that covers any disease of the heart and circulatory
More informationApproximately 70-80% of all strokes are ischemic and 20-30% are hemorrhagic Hemorrhagic stroke is defined as an acute neurologic injury resulting from bleeding in the brain There are two distinct types
More informationClinical Study Comprehensive CT Evaluation in Acute Ischemic Stroke: Impact on Diagnosis and Treatment Decisions
SAGE-Hindawi Access to Research Stroke Research and Treatment Volume 211, Article ID 72673, 1 pages doi:1.461/211/72673 Clinical Study Comprehensive CT Evaluation in Acute Ischemic Stroke: Impact on Diagnosis
More informationAHA/ASA Guideline. The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.
AHA/ASA Guideline Guidelines for the Early Management of Adults With Ischemic Stroke A Guideline From the American Heart Association/ American Stroke Association Stroke Council, Clinical Cardiology Council,
More informationAcute Stroke Diagnosis and Management
Acute Stroke Diagnosis and Management Dr Gemma Smith (Specialty Trainee in Elderly Care and Stroke Medicine) Correspondence - Gemma Smith: gem.eaton@gmail.com ABSTRACT Stroke (noun): a sudden disabling
More informationStroke Coding Issues Presentation to: NorthEast Cerebrovascular Consortium
Stroke Coding Issues Presentation to: NorthEast Cerebrovascular Consortium October 30, 2008 Barry Libman, RHIA, CCS, CCS-P President, Barry Libman Inc. Stroke Coding Issues Outline Medical record documentation
More informationCode Stroke: Early Recognition and Emergency Management of the Acute Stroke Patient
Code Stroke: Early Recognition and Emergency Management of the Acute Stroke Patient Ali Grubbs, RN BSN Clinical Staff Leader VUMC Adult Emergency Department Vanderbilt Adult Emergency Department Patient
More informationA Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation
Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation A Patient s Guide to Antithrombotic Therapy in Atrial Fibrillation PATIENT EDUCATION GUIDE What is atrial fibrillation? Atrial fibrillation
More informationImaging of Acute Stroke. Noam Eshkar, M.D New Jersey Neuroscience Institute JFK Medical Center Edison Radiology Group
Imaging of Acute Stroke Noam Eshkar, M.D New Jersey Neuroscience Institute JFK Medical Center Edison Radiology Group Modalities Non Contrast CT (NCCT) Contrast CT Angiography MRI MR Angiography Perfusion
More informationAHA/ASA Ischemic Stroke Performance Measures
AHA/ASA Ischemic Stroke Performance Measures 1. Venous thromboembolism prophylaxis Percentage of patients with ischemic stroke who receive venous thromboembolism prophylaxis Numerator Hospital day 0 or
More informationStroke affects approximately 795,000 persons in the
CLINICAL ASSESSMENT OF STROKE: AREVIEW FOR ED NURSES Authors: Karen Bergman, RN, PhDc, Dean Kindler, MD, and Lindsy Pfau, RN, Kalamazoo, MI Stroke affects approximately 795,000 persons in the United States
More informationAdvances in Stroke Care
Advances in Stroke Care 2015 Friday October 2 7 a.m. to 4:30 p.m. Hyatt Regency New Brunswick Two Albany Street New Brunswick, NJ 08901 Jointly sponsored by the Comprehensive Stroke Center Robert Wood
More informationMechanical Embolectomy for Treatment of Acute Stroke. Original Policy Date
MP 2.01.49 Mechanical Embolectomy for Treatment of Acute Stroke Medical Policy Section Medicine Issue 12:2013 Original Policy Date 12:2013 Last Review Status/Date Reviewed with literature search/12:2013
More information4th Annual New York Stroke Conference Maximizing Stroke Quality of Care: Key Ingredients
4th Annual New York Stroke Conference Maximizing Stroke Quality of Care: Key Ingredients Thomas Kwiatkowski, MD Medical Director : Center for Emergency Medical Services NSLIJ No relevant financial relationships
More informationSTATEMENT OF STANDARD
OHSU HEALTH CARE SYSTEM PRACTICE STANDARD Acute Stroke Practice Standard for the Emergency Department (includes ischemic stroke, TIAs, intracerebral hemorrhage, and non-subarachnoid hemorrhage), PS 01.11
More informationEvolution of Reperfusion Therapies for Acute Brain and Acute Myocardial Ischemia A Systematic, Comparative Analysis
Evolution of Reperfusion Therapies for Acute Brain and Acute Myocardial Ischemia A Systematic, Comparative Analysis Richa D. Patel, BS; Jeffrey L. Saver, MD Background and Purpose Early reperfusion is
More informationSTANDARDS OF PRACTICE
STANDARDS OF PRACTICE Multisociety Consensus Quality Improvement Guidelines for Intraarterial Catheter-directed Treatment of Acute Ischemic Stroke, from the American Society of Neuroradiology, Canadian
More informationDuration of Dual Antiplatelet Therapy After Coronary Stenting
Duration of Dual Antiplatelet Therapy After Coronary Stenting C. DEAN KATSAMAKIS, DO, FACC, FSCAI INTERVENTIONAL CARDIOLOGIST ADVOCATE LUTHERAN GENERAL HOSPITAL INTRODUCTION Coronary artery stents are
More informationKevin Saunders MD CCFP Rivergrove Medical Clinic Wellness Institute @ SOGH April 17 2013
Kevin Saunders MD CCFP Rivergrove Medical Clinic Wellness Institute @ SOGH April 17 2013 Family physician with Rivergrove Medical Clinic Practice in the north end since 1985 Medical Director of the Wellness
More informationNnEeWw DdEeVvEeLlOoPpMmEeNnTtSs IiıNn OoRrAaLl AaNnTtIiıCcOoAaGgUuLlAaTtIiıOoNn AaNnDd RrEeVvEeRrSsAaLl
NnEeWw DdEeVvEeLlOoPpMmEeNnTtSs IiıNn OoRrAaLl AaNnTtIiıCcOoAaGgUuLlAaTtIiıOoNn AaNnDd RrEeVvEeRrSsAaLl Mikele Wissing, RN June 2014 Introduction until recently, was the unrivaled medication for treatment
More informationFailure or significant adverse effects to all of the alternatives: Eliquis and Xarelto
This policy has been developed through review of medical literature, consideration of medical necessity, generally accepted medical practice standards, and approved by the IEHP Pharmacy and Therapeutics
More informationHow To Treat Aneuricaagulation
Speaker Introduction Jessica Wilhoite, PharmD, BCACP Doctor of Pharmacy: Purdue University Postgraduate Residency Training: PGY1 Pharmacy Practice St. Vincent Hospital PGY2 Ambulatory Care St. Vincent
More informationBasic Stroke for the New Recruit
Basic Stroke for the New Recruit Authors Erin Conahan MSN, RN, ACNS-BC, CNRN, SCRN Julie FussnerBSN, RN, CPHQ, SCRN The authors have nothing to disclose. 1 Objectives List causes of small vessel stroke
More informationDiscovery of an Aneurysm Following a Motorcycle Accident. Maya Babu, MSIII Gillian Lieberman, M.D.
Discovery of an Aneurysm Following a Motorcycle Accident Maya Babu, MSIII Gillian Lieberman, M.D. Patient CC: July 2004 65 yo male transferred to the BI from an OSH s/p motorcycle crash w/o a helmet CC
More informationDabigatran (Pradaxa) Guidelines
Dabigatran (Pradaxa) Guidelines Dabigatran is a new anticoagulant for reducing the risk of stroke in patients with atrial fibrillation. Dabigatran is a direct thrombin inhibitor, similar to warfarin, without
More informationWhat is the Role of Telestroke in Stroke Systems of Care?
What is the Role of Telestroke in Stroke Systems of Care? Jeffrey A. Switzer, D.O. Director of Telestroke and Teleneurology Vascular Neurology Georgia Health Sciences University Disclosures Funding/grant
More informationMobile Stroke Treatment Units: A New Systems Concept
Mobile Stroke Treatment Units: A New Systems Concept Peter A. Rasmussen, MD on behalf of the CV Center and CCT Director, Cerebrovascular Center Associate Professor Surgery (Neurosurgery) Medical Director
More informationLet s talk about: Stroke
Let s talk about: Stroke February 20 th 2013 Laura Wilson Christine Stables Questions 1. Why is knowing about stroke important? 2. What exactly is a stroke and what are the symptoms? 3. What should I do
More informationDepartment of Veterans Affairs VHA DIRECTIVE 2011-038 Veterans Health Administration Washington, DC 20420 November 2, 2011
Department of Veterans Affairs VHA DIRECTIVE 2011-038 Veterans Health Administration Washington, DC 20420 TREATMENT OF ACUTE ISCHEMIC STROKE (AIS) 1. PURPOSE: This Veterans Health Administration (VHA)
More informationEvidence-Based Secondary Stroke Prevention and Adherence to Guidelines
Evidence-Based Secondary Stroke Prevention and Adherence to Guidelines Mitchell S.V. Elkind, MD, MS Associate Professor of Neurology Columbia University New York, NY Presenter Disclosure Information Mitchell
More informationComplications off-licence. Tom Webb Tharani T-Chandran
Complications off-licence Tom Webb Tharani T-Chandran History 82 yr old collapsed at a restaurant Slumped to the Rt side Vacant and mute No obvious loss of consciousness No stereotypical movements Incontinent
More informationWhat You Should Know About Cerebral Aneurysms
What You Should Know About Cerebral Aneurysms From the Cerebrovascular Imaging and Interventions Committee of the American Heart Association Cardiovascular Radiology Council Randall T. Higashida, M.D.,
More informationSystolic Blood Pressure Intervention Trial (SPRINT) Principal Results
Systolic Blood Pressure Intervention Trial (SPRINT) Principal Results Paul K. Whelton, MB, MD, MSc Chair, SPRINT Steering Committee Tulane University School of Public Health and Tropical Medicine, and
More informationBrain Attacks and Acute Stroke Management
Brain Attacks and Acute Stroke Management WWW.RN.ORG Reviewed March, 2015, Expires March, 2017 Provider Information and Specifics available on our Website Unauthorized Distribution Prohibited 2015 RN.ORG,
More informationGlobal Objectives. Use of the NIH Stroke Scale (NIHSS) in Emergency Department Patients with Acute Stroke. Why Do This Exercise? Session Objectives
1 Use of the NIH Scale (NIHSS) in Emergency Department Patients with Acute Professor Department of Emergency Medicine University of Illinois College of Medicine Chicago, IL Global Objectives Improve pt
More informationThe 50-year Quest to Replace Warfarin: Novel Anticoagulants Define a New Era. CCRN State of the Heart 2012 June 2, 2012
The 50-year Quest to Replace Warfarin: Novel Anticoagulants Define a New Era CCRN State of the Heart 2012 June 2, 2012 Disclosures I have I have been involved in trials of new anticoagulants and have received
More informationNovel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations
Novel oral anticoagulant (NOAC) for stroke prevention in atrial fibrillation Special situations Dardo E. Ferrara MD Cardiac Electrophysiology North Cascade Cardiology PeaceHealth Medical Group Which anticoagulant
More informationLong term anticoagulant therapy in patients with atrial fibrillation at high risk of stroke: a new scenario after RE-LY trial
Long term anticoagulant therapy in patients with atrial fibrillation at high risk of stroke: a new scenario after RE-LY trial Camillo Autore Università di Roma Sapienza II Facoltà di Medicina e Chirurgia
More informationHow To Help A Stroke Patient
Rishi Gupta, MD Susan Zimmermann, RN, BSN, CNRN Kerrin Connelly, RN, MSN, MPH Cheri Kommor, RN, CEN, CFRN, NREMT-P Rishi Gupta FINANCIAL DISCLOSURE: Consultant: Stryker Neurovascular, Covidien DSMB: Rapid
More informationJHS Stroke Program. 2016 JHS Annual Mandatory Education
JHS Stroke Program 2016 JHS Annual Mandatory Education Learner Objectives At the conclusion of this module learners will be able to: State the definition of stroke Discuss the pathophysiology of stroke
More informationACUTE STROKE REGISTRY (NJASR) VERSION 2.0) (Continued)
New Jersey Department of Health ACUTE STROKE REGISTRY (NJASR) VERSION 2.0 A. DEMOGRAPHIC DATA *Hospital Type (1): 1=Primary 2=Comprehensive 3=Other *Hospital Code (2): *Hospital Transferred From Code (3):
More informationDISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD
STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with
More informationDual Antiplatelet Therapy. Stephen Monroe, MD FACC Chattanooga Heart Institute
Dual Antiplatelet Therapy Stephen Monroe, MD FACC Chattanooga Heart Institute Scope of Talk Identify the antiplatelet drugs and their mechanisms of action Review dual antiplatelet therapy in: The medical
More informationPrescriber Guide. 20mg. 15mg. Simply Protecting More Patients. Simply Protecting More Patients
Prescriber Guide 20mg Simply Protecting More Patients 15mg Simply Protecting More Patients 1 Dear Doctor, This prescriber guide was produced by Bayer Israel in cooperation with the Ministry of Health as
More informationIschemic stroke is a syndrome of multiple etiologies and
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke Gregory W. Albers, MD, Chair; Pierre Amarenco, MD; J. Donald Easton, MD; Ralph L. Sacco, MD; and Philip Teal, MD Abbreviations: ACE ASA and Carotid
More informationAnticoagulation before and after cardioversion; which and for how long
Anticoagulation before and after cardioversion; which and for how long Sameh Samir, MD Cardiovascular medicine dept. Tanta faculty of medicine Atrial fibrillation goals of management Identify and treat
More informationApproved: Acute Stroke Ready Hospital Advanced Certification Program
Approved: Acute Stroke Ready Hospital Advanced Certification Program The Joint Commission recently developed a new Disease- Specific Care Advanced Certification program for Acute Stroke Ready Hospitals
More informationManagement of Acute Ischemic Stroke and Transient Ischemic Attack
Management of Acute Ischemic Stroke and Transient Ischemic Attack By Xi Liu-DeRyke, Pharm.D.; and Kathleen A. Baldwin, Pharm.D., M.A., BCPS Reviewed by Jessica A. Starr, Pharm.D., BCPS; and Emilie L. Karpiuk,
More informationAcute Stroke: Evaluation and Treatment
Evidence Report/Technology Assessment Number 127 Acute Stroke: Evaluation and Treatment Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither
More informationMEDICAL POLICY. SUBJECT: ENDOVASCULAR TREATMENT OF ACUTE ISCHEMIC STROKE (e.g. MECHANICAL EMBOLECTOMY)
MEDICAL POLICY SUBJECT: ENDOVASCULAR TREATMENT OF PAGE: 1 OF: 12 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical
More informationAtrial Fibrillation, Chronic - Antithrombotic Treatment - OBSOLETE
Atrial Fibrillation, Chronic - Antithrombotic Treatment - OBSOLETE Clinical practice guidelines serve as an educational reference, and do not supersede the clinical judgment of the treating physician with
More informationWhat Is an Arteriovenous Malformation (AVM)?
What Is an Arteriovenous Malformation (AVM)? From the Cerebrovascular Imaging and Intervention Committee of the American Heart Association Cardiovascular Council Randall T. Higashida, M.D., Chair 1 What
More informationStroke And Multiple Sclerosis. 2013 ACOI Internal Medicine Review Course Scott Spradlin D.O. FACOI
Stroke And Multiple Sclerosis 2013 ACOI Internal Medicine Review Course Scott Spradlin D.O. FACOI Stroke 3 rd Leading cause of Death Acute brain injury due to a vascular cause Sudden onset Persist at least
More informationSecondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence
Guidelines Secondary Stroke Prevention Luke Bradbury, MD 10/4/14 Fall WAPA Conferfence Stroke/TIA Nearly 700,000 ischemic strokes and 240,000 TIAs every year in the United States Currently, the risk for
More informationInvestor News. Phase III J-ROCKET AF Study of Bayer s Xarelto (rivaroxaban) Meets Primary Endpoint. Not intended for U.S.
Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Phase III J-ROCKET AF Study of Bayer s Xarelto (rivaroxaban) Meets Primary Endpoint
More informationAppendix L: HQO Year 1 Implementation Priorities
Appendix L: HQO Year 1 Implementation Priorities Chronic Obstructive Pulmonary Disease (Source: COPD Chairs) Non-Invasive Positive Pressure Ventilation Early Ambulation If possible, seek patient preferences
More informationStroke Care First week
Stroke Care First week Florence Nightingale (1820 1910) Stroke Unit Dedicated personnel trained in stroke management Stepwise guidelines supported by explicit checklists Continuous monitoring available
More informationAntiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty
Round Table: Antithrombotic therapy beyond ACS Antiplatelet and anticoagulation treatment of patients undergoing carotid and peripheral artery angioplasty M. Matsagkas, MD, PhD, EBSQ-Vasc Associate Professor
More information